✦ LIBER ✦

Short-term interferon-alfa therapy for acute hepatitis C: A randomized controlled trial

✍ Scribed by Hideyuki Nomura; Suketo Sou; Hironori Tanimoto; Takashi Nagahama; Yoichi Kimura; Jun Hayashi; Hiromi Ishibashi; Seizaburo Kashiwagi

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 118 KB
Volume: 39
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.20196

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-α in acute posttransfusion he

Interferon-α in acute posttransfusion hepatitis C:. A randomized, controlled trial

✍ Lluis Viladomiu; Dr. Joan Genescà; Juan I. Esteban; Helena Allende; Antonio Gonz 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB

Therapy of hepatitis C: Interferon alfa-

Therapy of hepatitis C: Interferon alfa-2a trials

✍ W M Lee 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB 👁 2 views

Interferon alfa-2a resembles other recombinant alpha inter-2a has recently been approved by the Food and Drug Administration for use as therapy of chronic hepatitis C in a regimen ferons in structure and pharmacology. Studies delineating its efficacy suggest that after 6 to 12 months of therapy, sus

A randomized controlled trial of high-do

A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis C

✍ Di Marco, Vito; Lo Iacono, Oreste; Cammà, Calogero; Almasio, Piero L.; Vaccaro, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

In chronic hepatitis C virus (HCV) infection, the rate of sustained response to interferon is low. We evaluated, in patients responding to a 26-week course of interferon, the effect of high-dose maintenance therapy in preventing relapse. Three hundred and ten patients with chronic HCV infection (38.

A prospective, randomized trial comparin

A prospective, randomized trial comparing lymphoblastoid to recombinant interferon alfa 2a as therapy for chronic hepatitis C

✍ M Rumi; E Del Ninno; M L Parravicini; R Romeo; R Soffredini; M F Donato; J Wilbe 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

Duration of peginterferon therapy in acu

Duration of peginterferon therapy in acute hepatitis C: A randomized trial

✍ Sanaa M. Kamal; Khairy N. Moustafa; Jason Chen; Jutta Fehr; Azza Abdel Moneim; K 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB 👁 1 views

Spontaneous resolution of acute hepatitis C virus infection cannot be predicted, and chronic evolution of the disease occurs in a majority of cases. To assess the efficacy and safety of peginterferon alpha-2b administered for 8, 12, or 24 weeks in patients with acute hepatitis C virus infection a to

Peginterferon alfa-2a for hepatitis C af

Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials

✍ Naga Chalasani; Cosme Manzarbeitia; Peter Ferenci; Wolfgang Vogel; Robert J. Fon 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB 👁 1 views

There is currently no effective treatment for recurrent hepatitis C after orthotopic liver transplantation (OLT). We therefore performed two randomized, controlled trials-a prophylaxis trial and a treatment trial-to evaluate the safety and efficacy of peginterferon alfa-2a in patients who had underg